Govt Makes Unique ID Mandatory For Doctors

New Delhi : Doctors will now have to get a Unique Identification Number (UID) to be able to practice medicine in the country, as per the new regulations by the National Medical Commission (NMC).

The UID will be generated centrally by the NMC ethics board and thereby grant the practitioner registration in NMR and eligibility to practice medicine in India.

According to the new notification by NMC, there will be a common national medical register for all the registered medical practitioners of the country. The same will be maintained by the Ethics and Medical Registration Board (EMRB) under the NMC. This register will contain all the entries of the registered medical practitioners of all State Registers maintained by the various State Medical Councils and will have all relevant information regarding the medical practitioner.

The licence to practice medicine issued to a registered medical practitioner will be valid for a period of five years after which the medical practitioner will have to renew the licencing by making an application to the State Medical Council, said the new notification-“Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023”.

The application for renewal of licence may be made before three month of expiration of the validity of licence, it said.

  • Related Posts

    DCGI Greenlights Akums’ Extended-Release NVP Tablet: A First for India’s Pharma Sector

    In a move poised to redefine drug delivery in maternal healthcare, Akums Drugs & Pharmaceuticals Ltd.—India’s leading pharmaceutical contract development and manufacturing organisation (CDMO)—has secured a patent for its novel…

    Tatva Chintan Pharma slides as Q4 PAT drops 89% YoY to Rs 1 cr

    Tatva Chintan Pharma Chem declined 2.85% to Rs 684 after the company’s consolidated net profit tanked 89.28% to Rs 1.03 crore in Q4 FY25, compared with Rs 9.61 crore psoted…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    DCGI Greenlights Akums’ Extended-Release NVP Tablet: A First for India’s Pharma Sector

    DCGI Greenlights Akums’ Extended-Release NVP Tablet: A First for India’s Pharma Sector

    Tatva Chintan Pharma slides as Q4 PAT drops 89% YoY to Rs 1 cr

    Tatva Chintan Pharma slides as Q4 PAT drops 89% YoY to Rs 1 cr

    Panel to take a call on doorstep medicine delivery

    Panel to take a call on doorstep medicine delivery

    Rajasthan govt set to revive Rajasthan Drugs and Pharma

    Rajasthan govt set to revive Rajasthan Drugs and Pharma